chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bald spot developed on the back of my head. I went to get my hair done and my hairdresser discovered a large bald patch near the back of my hairline, near my right ear.
patient received vaccine past its 30 days expiry date/ Vaccines went in to 2-8 C thaw state; patient received vaccine past its 30 days expiry date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (patient received vaccine past its 30 days expiry date/ Vaccines went in to 2-8 C thaw state) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     It was unknown if the patient had acute illness at the time of vaccination and up to one month before. It was unknown if the patient had chronic or long lasting health conditions.   On 02-Apr-2022 at 10:49 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022 at 10:49 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (patient received vaccine past its 30 days expiry date/ Vaccines went in to 2-8 C thaw state). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (patient received vaccine past its 30 days expiry date/ Vaccines went in to 2-8 C thaw state) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient's ethnicity was reported. It was unknown if the patient received any prescriptions, over the counter medications, dietary supplements or herbal remedies at the time of vaccination. It was unknown if the patient received other vaccines given on the same day and it was also unknown if the patient received other vaccines within one month prior to Moderna vaccine. It was reported that, the vaccines went in to 2-8 C thaw state on or about 24-Dec-2021. It was unknown if the patient experienced any adverse events or not. No treatment medications were reported.
3rd, 4th,5th and 6th Cranial nerve palsies. 98% Resolved overtime 3 years later still have residual visual disturbances.
Patient received injection and in the AM woke up with rash around eyes, as day progressed the rash progressed over the entire body.
On 3/2/2021 at about noon, I felt incredibly tired. I was so tired that I had to leave work and go home. I experienced fever, chills, body aches, and headaches. I had these symptoms for about 20 hours. After that, I felt fine.
I had an adverse reaction to the second shot. I was shaking and had a fever spiking on and off for two days. Tinnitus started about a week after the second shot.
SORE ARM, RASH 4" in length-3" below site of shot, NAUSEUS, PUNKY FEELING, NO APPETITE ALL DAY WEDNESDAY (day after shot)
EXTREME PAIN IN ARM PIT AND INSIDE UPPER ARM OF ARM THE VACCINE WAS ADMINISTERED THE DAY AFTER. ON 2ND DAY AFTER THE PAIN WAS CONSTANT WITH BURNING PAIN IF TOUCHED AT THE INSIDE UPPER ARM. ON 3RD DAY AFTER DULL ACHE WITH BURNING PAIN IF TOUCHED. ON 4TH DAY AFTER DULL ACHE WITH TIGHT FEELING IN ARMPIT AND INSIDE UPPER ARM AND STILL BURNING PAIN IF TOUCHED OR PRESSED ON. ON DAY I TOOK OTC TYLENOL DAY 2 TOOK TYLENOL, TYLENOL PM AND ICED AREA DAY 3 TOOK ALEVE AND HEATING PAD ON AREA DAY 4 TOOK ALEVE
The vaccine injection was given at 1:15PM. Symptoms started 8 hours later at 9:00PM.  After the first bout of vomiting on night #1, symptoms diminished in intensity but continued into the next day until 10:00PM (when the fever finally broke) for a total of 25 hours. Took 200mg Advil/ibuprofen x 1 dose for relief/sleep on night #1. The symptoms included the following: 1. Chills w/ intense body shivering 2. All over body aches 3. Nausea 4. Violent vomiting 5. Fever 100.3F at the onset  6. Fever 99.9F the following day 7. Headache 8. Extreme tiredness (eyelids felt like lead weights) 9. Dizziness 10. Minimal to no pain at the injection site (very mild if pressing on the skin below the site)
Redness, inflammation, hot to touch. Reported to clinic on 3rd day on Nov 7th.
Continued High Blood pressure. Following first booster my normal 100/70 blood pressure raised to 158/95. It eventually settled to 123/80.  Following the second booster it went high again but has remained high.  BP checks this week 147/90 and booster was received 3 months ago.  Do not know if this will reamain or eventually go back.
Patient presented to the pharmacy with a local red area at injection site. Feld warm to touch and complained her arm was in pain. It looked like an allergic response to one of the injection.
This spontaneous report was received from a healthcare worker refers to a patient of unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On 08-JAN-2015, the patient was vaccinated with the first dose of VAQTA, (strength, dose, route, anatomical location, lot number and expiration date were not reported). Other suspect and concomitant therapies were not reported. The reporter indicated that on 30-MAR-2015, the patient was inadvertently vaccinated with the second dose of VAQTA (strength, dose, route, anatomical location, lot number and expiration date were not reported). No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
Patients administered Moderna vaccine while temperature excursion assessment was ongoing; Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  The reporter stated that their facility was not able to download the digital data logger, they had been put on hold at the moment. They would need to treat this issue as a temperature excursion. There had been no power outages that would have impacted the Moderna vaccine. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. The reporter did not have any questions and wanted to report this to Moderna.  The reporter stated that no adverse reactions were reported by any patients.
Soreness/knot under armpit, tingling/numbness in hand, injection site still sore after 5 days.
Weakness, body aches, joint pain, left arm in pain, intermittent pain in right thigh
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Feb2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 60 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing), notes: HTN; "Known allergies: PCN" (unspecified if ongoing), notes: Known allergies: PCN; "Known allergies: S" (unspecified if ongoing), notes: Known allergies: S; "Known allergies: ACEI" (unspecified if ongoing), notes: Known allergies: ACEI. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the known safety profile and Limited information in the case report, a casual association between reported events and the suspect drug cannot be excluded.
freezing cold hands; tingly hands, kinda numb/from my knees down lots of tingling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (freezing cold hands) and PARAESTHESIA (tingly hands, kinda numb/from my knees down lots of tingling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL COLDNESS (freezing cold hands) and PARAESTHESIA (tingly hands, kinda numb/from my knees down lots of tingling). At the time of the report, PERIPHERAL COLDNESS (freezing cold hands) and PARAESTHESIA (tingly hands, kinda numb/from my knees down lots of tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 26-Jan-2021: No specific follow-up information recorded.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old patient received BNT162b2 (BNT162B2), on 26Nov2021 as dose 3 (booster), single (Lot number: FG3527) at the age of 32 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "anxiety" (unspecified if ongoing); "peanuts" (unspecified if ongoing), notes: known allergies peanuts; "seasonal allergies" (unspecified if ongoing), notes: seasonal allergies; "acid reflux" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: Treatment of COVID-19; (Jul2022) Positive, notes: positive rapid test on day 17. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included treatment with paxlovid from 06Jul2022 to 10Jul2022.
pt recvd vax & devel a wheal & flare @ inject site which was described as white welts in a flat red area which persisted for 10 mins;
3 hours post: itch/warm/sore. White ring w/red rash. Sunday AM (next morning) Hot to touch red very swollen blisters (pin pop) went to ER - given KEFLEX.
chills; Due to COVID, he has not gotten his second dose yet; shaking; This case was reported by a nurse via call center representative and described the occurrence of tremor in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 28th November 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced tremor, chills and social problem. On an unknown date, the outcome of the tremor, chills and social problem were unknown.   It was unknown if the reporter considered the tremor and chills to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received Shingrix and experienced shaking and chills. The patient also reported due to COVID had not gotten his second dose yet. The reporter did not consent to follow up and did not wish to be contacted.
Muscle pain; tiredness; This is a spontaneous report from a non-contactable consumer or other non hcp. A 40-years-oldnon-pregnant female patient received first dose of bnt162b2 (covid 19 vaccine, formulation: solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Arm Right on 04Feb2021 (at the age of 40-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included from an unknown date and unknown if ongoing Other medical history: No. The patient had no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. The patient's concomitant medications were not reported. On 04Feb2021, the patient experienced muscle pain, tiredness. Therapeutic measures were taken as a result of muscle pain (myalgia), tiredness (fatigue).The outcome of the events was recovered.  No follow-up attempts are possible. No further information is expected.
Swollen arm; Tightness around arm; Fingers hurting (not getting better); Arm is hurting (waking up in the morning),but she still has pain in her arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Jun-2021 and was forwarded to Moderna on 01-Jun-2021.    This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), MUSCLE TIGHTNESS (Tightness around arm), PAIN IN EXTREMITY (Fingers hurting (not getting better)) and MYALGIA (Arm is hurting (waking up in the morning),but she still has pain in her arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medication history was provided.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm), MUSCLE TIGHTNESS (Tightness around arm), PAIN IN EXTREMITY (Fingers hurting (not getting better)) and MYALGIA (Arm is hurting (waking up in the morning),but she still has pain in her arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm), MUSCLE TIGHTNESS (Tightness around arm), PAIN IN EXTREMITY (Fingers hurting (not getting better)) and MYALGIA (Arm is hurting (waking up in the morning),but she still has pain in her arm) outcome was unknown.            Concomitant medication use was unknown  Treatment information was not provided.
Patient states that the vaccination hurt more than usual during the shot and the pain in her arm continued over the next few days.  Today 10/28/19 when she reported this event she describes being unable to fully lift her left arm and is still experiencing pain at the injection site.  Patient has been advised to see her PCP, for examination of her left arm.
facial swelling, stomach pains, no feeling upper part of head & rt side of back; went to ER 5NOV92; 2AM; given DPH;
pt recv vax;hives appeared w/in 4 hrs of vax on body;tx w/ pred & dph;mom stated that rash disappeared when she picked up daughter from school
Extreme flu like symptoms. Achy all over, dizzy, could not get out of bed for about 12 hours. Felt like hit by a truck! I never miss work, but took a full sick day. Then a quick recovery.
DTAP and IPV shots given in pt's right arm with swelling, warm to touch and redness at the site. Pt is itching at the site.
Several hours after receiving the vaccination, I began to experience severe stomach pain and suffered from vomiting and diarrhea. The next morning (8/8/23) I woke up with vaginal bleeding and cramping  that is still continuing as of 8/9/23.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with doses of ZOSTAVAX (route and lot # not reported). The nurse reported that the office often saw patients that were diagnosed with the shingles after receiving ZOSTAVAX. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Pain in the arm, can't lift arm very well, still hurting 10 days after dose.
Shot administered on 11-2-15. S/s started on 11-6-15. I saw on 11-9-15 when she came in. Her Lt. arm (upper) had approx 4 inch W x 2 inch red raised area. This area was warm to touch and approx. mid forearm approx 2 inches below injection site. Denies any other s/s besides itching at site.
Generally sick early; Also her bottom lip swollen; Also her bottom lip and left side of the face were swollen; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Generally sick early), LIP SWELLING (Also her bottom lip swollen) and SWELLING FACE (Also her bottom lip and left side of the face were swollen) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Generally sick early), LIP SWELLING (Also her bottom lip swollen) and SWELLING FACE (Also her bottom lip and left side of the face were swollen). At the time of the report, ILLNESS (Generally sick early), LIP SWELLING (Also her bottom lip swollen) and SWELLING FACE (Also her bottom lip and left side of the face were swollen) outcome was unknown.            No Concomitant Medication was provided. No treatment  was provided.   This case was linked to MOD-2021-385757 (Patient Link).
-Woke up the next day w/ a rash on whole arm. -painful arm even 3weeks later
This is a spontaneous report from a contactable consumer reporting for her husband. A 76-year-old male patient received the 2nd dose of PREVNAR 13, via an unspecified route of administration, on 01Aug2017 around 10:00/10:30 AM, at single dose, for immunisation. Relevant medical history included pain in knee and blood pressure abnormal (on medication since a long time). Concomitant medications included VITAMIN B 12, calcium (unspecified trade name), magnesium (unspecified trade name) and potassium (unspecified trade name). The patient previously received the 1st dose of PREVNAR 13 on an unspecified date for immunisation. The patient experienced lot of muscle pain on 01Aug2017 with outcome of unknown, chills on 01Aug2017 with outcome of not recovered, felt like he had a flu reaction on 01Aug2017 with outcome of unknown, all his joints hurt on 01Aug2017 with outcome of unknown, the pain that was in his upper arm has moved down into biceps on an unspecified date in Aug2017 with outcome of not recovered.
pt returned to the pharmacy within a week of receiving the influenza vaccination. she complained of heavy bruising, yellowing of the skin, and pain/tenderness near the injection site.  pt mentioned she is taking OTC pain killers to treat it.
rt arm pain that continued till visit to pcp 11/1/22.  advised to see 11/8/22  Dr and received x-ray and cortisone shot, then went for second opinion11/30/22 to Dr who x-rayed and prescribed pain meds, returned 1/4/23 to Dr prescribed dose pack, third visit 2/8/23 Dr ordered MRI, Mri  on 2/21/23 showed rotator cuff tear, Dr 3/1/23 set up surgery to repair 4/6/23. This was a mandated shot from (employer) by nurse at facility
Vaccine given on 1/7/21. On 1/11/21, I had my routine yearly required Quantiferon drawn. (I did not know about the recommendation to delay TB testing until four weeks after COVID vaccination.) That Quantiferon was positive, but we suspected it was related to the vaccine. I waited another four weeks and repeated the Quantiferon. The second Quantiferon was negative, making it very likely that the first was a false positive. It is interesting that this false positive came four days after the COVID vaccine.
Patient experienced redness, inflammation, soreness, warm to touch and itching at the vaccination site. Patient was recommended to take ibuprofen, apply BENADRYL cream and ice packing. We called the patient 2 days later and she said everything is fine and no symptoms.
flu-like muscular ache - 2 days, diarrhea 1 day
Confused; Can hardly hear; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, batch/lot number and expiry date were not reported), via an unspecified route of administration as a Dose 1, Single for COVID-19 immunization. The patient's medical history and Concomitant medication(s) were not reported. Patient was confused. Patient got this card. They did not tell patient had to call to get an appointment. Patient could hardly hear you. The Outcome of the events was unknown.  Information about lot/batch number has been requested.  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
large red, swollen area lt deltoid w/itching;also c/o h/a & feeling weak;advised to see pvt MD;
03/02/2000 Grandmother stated that the hand was red and swollen as well as the arm. She stated that they called doctor but could not be seen until later that day. Grandmother administered Tylenol and cancelled the doctor's appointment. Pt also thought that she had been 'shot' twice. She attended school that day.
Pt received vaccines and shortly after (about 10 minutes), broke out in hives (generalized) and wheezing/SOB.